Cinctive Capital Management’s Moderna MRNA Stock Holding History

Cinctive Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.13M	Sell	58,940 -17,103	-22%	-$885K	0.15%	191
2026 Q1	$3.86M	Buy	76,043 +3,667	+5%	+$171K	0.25%	137
2025 Q4	$2.13M	Buy	+72,376	New	+$1.97M	0.12%	203
2025 Q1	–	Sell	-15,842	Closed	-$659K	–	411
2024 Q4	$659K	Buy	+15,842	New	+$757K	0.03%	305
2022 Q3	–	Sell	-10,487	Closed	-$1.5M	–	558
2022 Q2	$1.5M	Buy	+10,487	New	+$1.5M	0.06%	338
2021 Q1	–	Sell	-2,847	Closed	-$297K	–	471
2020 Q4	$297K	Buy	+2,847	New	+$288K	0.02%	304

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Cinctive Capital Management's MRNA Position: Q2 2026 in Review

Cinctive Capital Management reduced its Moderna (MRNA) stake by 22% in Q2 2026, selling an estimated $885K and leaving 58,940 shares worth $4.13M. The position accounts for 0.15% of the portfolio, ranked #191.

Cinctive Capital Management first reported a position in MRNA in Q4 2020 and has held it in 6 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Cinctive Capital Management held 58,940 shares of Moderna worth $4.13M as of Q2 2026.
Cinctive Capital Management sold 17,103 Moderna shares in Q2 2026, an estimated $885K.
Moderna made up 0.15% of Cinctive Capital Management's portfolio in Q2 2026, its #191 holding.
Cinctive Capital Management first reported a position in Moderna in Q4 2020 and has held it in 6 quarters since.
780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.